Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026)
Rockwell Medical (RMTI) reported Change in Account Payables of $1.4 million for Q1 2026, up 253.18% on a YoY basis from $409425.3 in Q1 2025, and up 205.06% quarter-over-quarter from $474000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Change in Account Payables for 17 years, with the latest figure at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 253.18% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 150.77% YoY), and the FY2025 full-year result was -$870000.0, up 47.18% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.4 million, up from $474000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.4 million in Q1 2026, with the low at -$2.0 million in Q3 2023.
- Historically, Change in Account Payables has averaged -$17294.1 across 5 years, with a median of $262000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 1933.03% — and 2026, when it soared 253.18%.
- Rockwell Medical's Change in Account Payables stood at $1.0 million in 2022, then plunged by 41.42% to $587000.0 in 2023, then slumped by 55.37% to $262000.0 in 2024, then soared by 80.92% to $474000.0 in 2025, then soared by 205.06% to $1.4 million in 2026.
- The last three Change in Account Payables figures came in at $1.4 million (Q1 2026), $474000.0 (Q4 2025), and $23000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Rockwell Medical | 27.32 Mn | 3.43 Mn | 2.90 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 474,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Dec 31, 2023 | 587,000.00 |
| Dec 31, 2023 | 587,000.00 |